Please Wait.....
Report
Global Endoscopic Hemostasis Market
Market Report I 2026-01-01 I 350 Pages I Data Bridge Market Research
The global Endoscopic Hemostasis Market is expected to reach USD 4.24 billion by 2033 from USD 2.36 billion in 2025, growing with a substantial CAGR of 8.1% in the forecast period of 2026 to 2033.
Market Segmentation:
Global Endoscopic Hemostasis Market, By Product Type (Mechanical Hemostasis Devices, Thermal Devices, Topical Agents And Injectables, and Others), Procedure (Upper Gastrointestinal Endoscopy, Lower Gastrointestinal Endoscopy, Bronchoscopic Hemostasis, and Others), By Application (Gastrointestinal Bleeding, Non-Gastrointestinal Bleeding, Trauma Management, and Others), By End User (Hospitals (Public and Private), Ambulatory Surgery Centers, Specialty Clinics, and Others), By Distribution Channel (Direct Sales and Indirect Sales), By Countries (U.S., Canada, Mexico, China, Japan, India, South Korea, Taiwan, Singapore, Thailand, Australia, Malaysia, Indonesia, Philippines, New Zealand, Rest of Asia-Pacific, Germany, France, U.K., Netherlands, Switzerland, Italy, Belgium, Spain, Russia, Turkey, Denmark, Norway, Poland, Finland, Sweden, Georgia, Rest of Europe, Brazil, Argentina, Colombia, Chile, Peru, Ecuador, Uruguay, Panama, Venezuela, Bolivia, Paraguay, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Qatar, Kuwait, Oman, Bahrain, Rest of Middle East and Africa)- Industry Trends and Forecast to 2033
Overview of Global Endoscopic Hemostasis Market Dynamics:
Drivers
- Rise in gastrointestinal bleeding cases
- Aging population driving increased demand for GI disorders
- Adoption of minimally invasive endoscopic procedures
- Rising awareness and expanded screening programs for gastrointestinal endoscopy
Restraints
- High cost and technical complexity of endoscopic hemostasis devices
- Limited awareness in low-income countries
Opportunities
- Technological advancements in hemostasis devices
- Expansion in emerging markets (Asia-Pacific, Latin America)
- Growing adoption of home-based and capsule endoscopy solutions
Market Players:
The key market players operating in the global Endoscopic Hemostasis Market are listed below:
- Micro-Tech Endoscopy (China)
- Taewoong Medical Co., Ltd. (South Korea)
- Ovesco Endoscopy AG (China)
- Apollo Endosurgery, Inc. (U.S.)
- Argon Medical Devices, Inc. (U.S.)
- Olympus Corporation (Japan)
- Boston Scientific Corporation (U.S.)
- CONMED Corporation (U.S.)
- Medtronic (Ireland)
- Cook (U.S.)
- ERBE Elektromedizin GmbH (China)
- Karl Storz SE & Co. KG (China)
- Pentax Medical (Japan)
- Endoskopie Technik Gerhard (China)
- Merit Medical Systems, Inc. (U.S.)
- Diversatek, Inc. (U.S.)
- STERIS plc (Japan)
- B. Braun SE (China)
- Duomed Group (Belgium)
TABLE OF CONTENTS
1 INTRODUCTION 85
1.1 OBJECTIVES OF THE STUDY 85
1.2 MARKET DEFINITION 85
1.3 OVERVIEW OF GLOBAL ENDOSCOPIC HEMOSTASIS MARKET 85
1.4 LIMITATIONS 87
1.5 MARKETS COVERED 88
2 MARKET SEGMENTATION 90
2.1 MARKETS COVERED 90
2.2 GEOGRAPHICAL SCOPE 91
2.3 YEARS CONSIDERED FOR THE STUDY 92
2.4 CURRENCY AND PRICING 92
2.5 DBMR TRIPOD DATA VALIDATION MODEL 93
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 96
2.7 MULTIVARIATE MODELLING 97
2.8 DBMR MARKET POSITION GRID 98
2.9 VENDOR SHARE ANALYSIS 99
2.10 MARKET END-USER COVERAGE GRID 100
2.11 SECONDARY SOURCES 101
2.12 ASSUMPTIONS 101
3 EXECUTIVE SUMMARY 102
4 PREMIUM INSIGHTS 108
4.1 PORTERS FIVE FORCES ANALYSIS 109
4.2 BRAND OUTLOOK 110
4.2.1 BRAND COMPARATIVE ANALYSIS OF KEY GLOBAL PLAYERS 110
4.2.1.1 BRAND COMPARATIVE NARRATIVE (ANALYTICAL OVERVIEW) 111
4.2.2 PRODUCT VS BRAND OVERVIEW - GLOBAL ENDOSCOPIC HEMOSTASIS MARKET 112
4.2.2.1 PRODUCT OVERVIEW - ENDOSCOPIC HEMOSTASIS DEVICES 112
4.2.2.2 BRAND OVERVIEW - INFLUENCE ON GLOBAL CLINICAL ADOPTION 112
4.3 CONSUMER BUYING BEHAVIOUR 113
4.3.1 CLINICAL EFFECTIVENESS AND PATIENT OUTCOMES 113
4.3.2 COST AND VALUE CONSIDERATIONS 113
4.3.3 COMPATIBILITY AND INTEGRATION 113
4.3.4 TRAINING REQUIREMENTS AND EASE OF USE 113
4.3.5 REIMBURSEMENT AND HEALTHCARE POLICY ALIGNMENT 113
4.3.6 PROCUREMENT PROCESSES AND BULK AGREEMENTS 114
4.3.7 INFLUENCE OF CLINICAL STAKEHOLDERS 114
4.3.8 TRENDS IN BUYER BEHAVIOUR 114
4.3.9 CONCLUSION 114
4.4 PATENT ANALYSIS 115
4.4.1 PATENT QUALITY AND STRENGTH - GLOBAL ENDOSCOPIC HEMOSTASIS MARKET 115
4.4.2 COUNTRY PATENT LANDSCAPE 115
4.4.3 IP STRATEGY AND MANAGEMENT 117
4.4.4 LICENSING AND COLLABORATION 117
4.5 RAW MATERIAL COVERAGE 119
4.5.1 METALLIC COMPONENTS AND ALLOY SYSTEMS 119
4.5.2 POLYMERIC AND SYNTHETIC MATERIALS 119
4.5.3 NATURAL AND BIOCOMPATIBLE MATERIALS 119
4.5.4 ELECTRICAL AND THERMAL MATERIAL SYSTEMS 120
4.5.5 EXPENDABLE ACCESSORIES AND SINGLE-USE MATERIALS 120
4.6 TECHNOLOGICAL ADVANCEMENTS IN GLOBAL ENDOSCOPIC HEMOSTASIS MARKET 121
4.6.1 ENHANCED MECHANICAL HEMOSTASIS TOOLS 121
4.6.2 ADVANCED THERMAL COAGULATION AND ENERGY-BASED SYSTEMS 121
4.6.3 NOVEL TOPICAL HEMOSTATIC AGENTS 121
4.6.4 INTEGRATION WITH ADJUNCTIVE DIAGNOSTIC TECHNOLOGIES 121
4.6.5 DEVELOPMENT OF MULTIFUNCTIONAL AND COMBINATION DEVICES 121
4.6.6 IMPROVED USER ERGONOMICS AND DEVICE DEPLOYMENT SYSTEMS 122
4.6.7 CONCLUSION 122
4.7 VALUE CHAIN ANALYSIS 123
4.7.1 OVERVIEW 123
4.7.2 RAW MATERIALS & COMPONENTS 123
4.7.3 DEVICE DESIGN, R&D & MANUFACTURING 124
4.7.4 PROCESSING, FINISHING & STERILIZATION 124
4.7.5 PACKAGING & LABELING 124
4.7.6 LOGISTICS, DISTRIBUTION & COMMERCIALIZATION 124
4.7.7 CONCLUSION 124
4.8 VENDOR SELECTION CRITERIA 125
4.8.1 CLINICAL PERFORMANCE 125
4.8.2 REGULATORY COMPLIANCE AND APPROVALS 125
4.8.3 COST AND TOTAL VALUE PROPOSITION 125
4.8.4 SUPPLY CHAIN ROBUSTNESS AND LOGISTICS 125
4.8.5 SUPPORT, TRAINING AND CLINICAL EDUCATION 125
4.8.6 QUALITY SYSTEMS AND REPROCESSING GUIDANCE 125
4.8.7 REPUTATION, PEER ACCEPTANCE AND POST-MARKET PERFORMANCE 125
4.8.8 INNOVATION AND FUTURE-READINESS 126
4.9 COMPANY EVALUATION QUADRANT 127
?
4.10 PROFIT MARGIN SCENARIO 129
4.10.1 MARGIN IMPROVEMENT DRIVERS 129
4.10.2 COST PRESSURE 129
4.10.3 REGIONAL VARIATIONS 129
4.10.4 FUTURE SCENARIOS 130
4.11 CLIMATE CHANGE SCENARIO 131
4.11.1 ENVIRONMENTAL CONCERNS 131
4.11.2 INDUSTRY RESPONSE 131
4.11.3 GOVERNMENT'S ROLE 131
4.11.4 ANALYST RECOMMENDATIONS 132
4.12 INNOVATION TRACKER AND STRATEGIC ANALYSIS 133
4.12.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 133
4.12.1.1 JOINT VENTURES 133
4.12.1.2 MERGERS AND ACQUISITIONS 133
4.12.1.3 LICENSING AND PARTNERSHIP 133
4.12.1.4 TECHNOLOGY COLLABORATIONS 133
4.12.2 STRATEGIC DIVESTMENTS 134
4.12.3 STAGE OF DEVELOPMENT 134
4.12.4 TIMELINES AND MILESTONES 134
4.12.5 INNOVATION STRATEGIES AND METHODOLOGIES 134
4.12.6 RISK ASSESSMENT AND MITIGATION 134
4.12.7 FUTURE OUTLOOK 135
4.13 PRICING ANALYSIS 136
4.13.1 HEMOSTATIC CLIPS AND FORCEPS PRICING 136
4.13.2 BANDING AND COAGULATION DEVICES 137
4.13.3 REGULATORY AND REIMBURSEMENT IMPACT 137
4.14 SUPPLY CHAIN ANALYSIS 138
4.14.1 OVERVIEW 138
4.14.2 LOGISTIC COST SCENARIO 138
4.14.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 138
4.14.4 CONCLUSION 139
5 TARIFFS & IMPACT ON THE MARKET 140
5.1 OVERVIEW 140
5.2 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 140
5.3 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 140
5.4 VENDOR SELECTION CRITERIA 141
?
5.5 IMPACT ON SUPPLY CHAIN 141
5.5.1 RAW MATERIAL PROCUREMENT 141
5.5.2 MANUFACTURING AND PRODUCTION 141
5.5.3 LOGISTICS AND DISTRIBUTION 141
5.5.4 PRICE PITCHING AND POSITION OF MARKET 141
5.6 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 141
5.6.1 SUPPLY CHAIN OPTIMIZATION 141
5.6.2 JOINT VENTURE ESTABLISHMENTS 141
5.7 IMPACT ON PRICES 142
5.8 REGULATORY INCLINATION 142
5.8.1 GEOPOLITICAL SITUATION 142
5.8.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 142
5.8.2.1 FREE TRADE AGREEMENTS 142
5.8.2.2 ALLIANCES ESTABLISHMENTS 142
5.8.3 STATUS ACCREDITATION (INCLUDING MFTN) 142
5.8.4 DOMESTIC COURSE OF CORRECTION 142
5.8.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 142
5.8.4.2 ESTABLISHMENT OF SEZS/INDUSTRIAL PARKS 142
6 REGULATION COVERAGE 143
6.1 PRODUCT CODES 143
6.2 CERTIFIED STANDARDS 143
6.3 SAFETY STANDARDS 144
6.3.1 MATERIAL HANDLING & STORAGE 144
6.3.2 TRANSPORT & PRECAUTIONS 144
6.3.3 HAZARD IDENTIFICATION 144
7 MARKET OVERVIEW 145
7.1 DRIVERS 147
7.1.1 RISE IN GASTROINTESTINAL BLEEDING CASES 147
7.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI DISORDERS 148
7.1.3 ADOPTION OF MINIMALLY INVASIVE ENDOSCOPIC PROCEDURES 149
7.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY 150
7.2 RESTRAINTS 151
7.2.1 HIGH COST AND TECHNICAL COMPLEXITY OF ENDOSCOPIC HEMOSTASIS DEVICES 151
7.2.2 LIMITED AWARENESS IN LOW-INCOME COUNTRIES 152
7.3 OPPORTUNITIES 153
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEMOSTASIS DEVICES 153
7.3.2 EXPANSION IN EMERGING MARKETS (ASIA-PACIFIC, LATIN AMERICA) 154
7.3.3 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS 155
7.4 CHALLENGES 156
7.4.1 REIMBURSEMENT ISSUES FOR ENDOSCOPIC PROCEDURES 156
7.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES 157
8 GLOBAL ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 158
8.1 OVERVIEW 159
8.2 MECHANICAL HEMOSTASIS DEVICES 162
8.2.1 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 162
8.2.1.1 HEMOSTATIC CLIPS 163
8.2.1.1.1 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE 163
8.2.1.1.1.1 THROUGH-THE-SCOPE (TTS) CLIPS 163
8.2.1.1.1.2 OVER-THE-SCOPE (OTS) CLIPS 163
8.2.1.1.2 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL 164
8.2.1.1.2.1 STAINLESS STEEL 164
8.2.1.1.2.2 TITANIUM 164
8.2.1.2 BANDING DEVICES 165
8.2.1.2.1 BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE 165
8.2.1.2.1.1 VARICEAL BANDING KITS 165
8.2.1.2.1.2 OESOPHAGEAL BANDING DEVICES 165
8.2.1.3 HEMOSTATIC FORCEPS 165
8.2.1.4 OTHERS 165
8.2.2 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 166
8.2.2.1 NORTH AMERICA 166
8.2.2.2 EUROPE 166
8.2.2.3 ASIA-PACIFIC 166
8.2.2.4 SOUTH AMERICA 166
8.2.2.5 MIDDLE EAST & AFRICA 166
8.3 THERMAL DEVICES 167
8.3.1 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 167
8.3.1.1 ARGON PLASMA COAGULATORS 167
8.3.1.2 HEATER PROBES 167
8.3.1.3 BIPOLAR COAGULATION DEVICES 167
8.3.1.3.1 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE 168
8.3.1.3.1.1 MONOPOLAR 168
8.3.1.3.1.2 BIPOLAR 168
?
8.3.1.3.2 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION 169
8.3.1.3.2.1 UPPER GI BLEEDING 169
8.3.1.3.2.2 LOWER GI BLEEDING 169
8.3.1.4 OTHERS 169
8.3.2 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 170
8.3.2.1 NORTH AMERICA 170
8.3.2.2 EUROPE 170
8.3.2.3 ASIA-PACIFIC 170
8.3.2.4 SOUTH AMERICA 170
8.3.2.5 MIDDLE EAST & AFRICA 170
8.4 TOPICAL AGENTS AND INJECTABLES 171
8.4.1 TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 171
8.4.1.1 EPINEPHRINE INJECTION 171
8.4.1.2 HEMOSTATIC SPRAY (POWDER) 171
8.4.1.3 HEMOSTATIC GELS 171
8.4.1.4 FIBRIN SEALANTS 172
8.4.1.5 SCLEROSING AGENTS 172
8.4.2 TOPICAL AGENTS AND INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 172
8.4.2.1 NORTH AMERICA 172
8.4.2.2 EUROPE 172
8.4.2.3 ASIA-PACIFIC 172
8.4.2.4 SOUTH AMERICA 173
8.4.2.5 MIDDLE EAST & AFRICA 173
8.5 OTHERS 173
8.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 173
8.5.1.1 NORTH AMERICA 173
8.5.1.2 EUROPE 173
8.5.1.3 ASIA-PACIFIC 174
8.5.1.4 SOUTH AMERICA 174
8.5.1.5 MIDDLE EAST & AFRICA 174
9 GLOBAL ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE TYPE 175
9.1 OVERVIEW 176
9.2 UPPER GASTROINTESTINAL ENDOSCOPY 178
9.2.1 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 178
9.2.1.1 BLEEDING ULCER MANAGEMENT 179
9.2.1.2 VARICEAL BLEEDING 179
9.2.1.3 DIEULAFOY LESION 179
9.2.2 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 179
9.2.2.1 NORTH AMERICA 179
9.2.2.2 EUROPE 179
9.2.2.3 ASIA-PACIFIC 180
9.2.2.4 SOUTH AMERICA 180
9.2.2.5 MIDDLE EAST & AFRICA 180
9.3 LOWER GASTROINTESTINAL ENDOSCOPY 180
9.3.1 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 180
9.3.1.1 COLONIC BLEEDING 180
9.3.1.2 DIVERTICULAR BLEEDING 181
9.3.2 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 181
9.3.2.1 NORTH AMERICA 181
9.3.2.2 EUROPE 181
9.3.2.3 ASIA-PACIFIC 181
9.3.2.4 SOUTH AMERICA 181
9.3.2.5 MIDDLE EAST & AFRICA 182
9.4 BRONCHOSCOPIC HEMOSTASIS 182
9.4.1 BRONCHOSCOPIC HEMOSTASIS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 182
9.4.1.1 NORTH AMERICA 182
9.4.1.2 EUROPE 182
9.4.1.3 ASIA-PACIFIC 182
9.4.1.4 SOUTH AMERICA 183
9.4.1.5 MIDDLE EAST & AFRICA 183
9.5 OTHERS 183
9.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 183
9.5.1.1 NORTH AMERICA 183
9.5.1.2 EUROPE 183
9.5.1.3 ASIA-PACIFIC 184
9.5.1.4 SOUTH AMERICA 184
9.5.1.5 MIDDLE EAST & AFRICA 184
?
10 GLOBAL ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION 185
10.1 OVERVIEW 186
10.2 GASTROINTESTINAL BLEEDING 189
10.2.1 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 189
10.2.1.1 PEPTIC ULCER BLEEDING 190
10.2.1.2 ESOPHAGEAL VARICES 190
10.2.1.3 COLORECTAL CANCERS 190
10.2.2 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 190
10.2.2.1 MECHANICAL HEMOSTASIS DEVICES 190
10.2.2.2 THERMAL DEVICES 191
10.2.2.3 TOPICAL AGENTS AND INJECTABLES 191
10.2.2.4 OTHERS 191
10.2.3 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 191
10.2.3.1 NORTH AMERICA 191
10.2.3.2 EUROPE 191
10.2.3.3 ASIA-PACIFIC 192
10.2.3.4 SOUTH AMERICA 192
10.2.3.5 MIDDLE EAST & AFRICA 192
10.3 NON-GASTROINTESTINAL BLEEDING 192
10.3.1 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 192
10.3.1.1 NASAL BLEEDING (EPISTAXIS) 192
10.3.1.2 POST-SURGICAL BLEEDING 193
10.3.2 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 193
10.3.2.1 MECHANICAL HEMOSTASIS DEVICES 193
10.3.2.2 THERMAL DEVICES 193
10.3.2.3 TOPICAL AGENTS & INJECTABLES 193
10.3.2.4 OTHERS 194
10.3.3 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND) 194
10.3.3.1 NORTH AMERICA 194
10.3.3.2 EUROPE 194
10.3.3.3 ASIA-PACIFIC 194
10.3.3.4 SOUTH AMERICA 194
10.3.3.5 MIDDLE EAST & AFRICA 195
?
10.4 TRAUMA MANAGEMENT 195
10.4.1 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 195
10.4.1.1 MECHANICAL HEMOSTASIS DEVICES 195
10.4.1.2 THERMAL DEVICES 195
10.4.1.3 TOPICAL AGENTS & INJECTABLES 196
10.4.1.4 OTHERS 196
10.4.2 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 196
10.4.2.1 NORTH AMERICA 196
10.4.2.2 EUROPE 196
10.4.2.3 ASIA-PACIFIC 196
10.4.2.4 SOUTH AMERICA 197
10.4.2.5 MIDDLE EAST & AFRICA 197
10.5 OTHERS 197
10.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 197
10.5.1.1 NORTH AMERICA 197
10.5.1.2 EUROPE 197
10.5.1.3 ASIA-PACIFIC 198
10.5.1.4 SOUTH AMERICA 198
10.5.1.5 MIDDLE EAST & AFRICA 198
11 GLOBAL ENDOSCOPIC HEMOSTASIS MARKET, BY END USER 199
11.1 OVERVIEW 200
11.2 HOSPITALS 203
11.2.1 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 203
11.2.1.1 PUBLIC 203
11.2.1.2 PRIVATE 203
11.2.2 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 204
11.2.2.1 NORTH AMERICA 204
11.2.2.2 EUROPE 204
11.2.2.3 ASIA-PACIFIC 204
11.2.2.4 SOUTH AMERICA 204
11.2.2.5 MIDDLE EAST & AFRICA 204
11.3 AMBULATORY SURGERY CENTERS 205
11.3.1 AMBULATORY SURGERY CENTERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 205
11.3.1.1 NORTH AMERICA 205
11.3.1.2 EUROPE 205
11.3.1.3 ASIA-PACIFIC 205
11.3.1.4 SOUTH AMERICA 205
11.3.1.5 MIDDLE EAST & AFRICA 206
?
11.4 SPECIALTY CLINICS 206
11.4.1 SPECIALTY CLINICS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 206
11.4.1.1 NORTH AMERICA 206
11.4.1.2 EUROPE 206
11.4.1.3 ASIA-PACIFIC 206
11.4.1.4 SOUTH AMERICA 207
11.4.1.5 MIDDLE EAST & AFRICA 207
11.5 OTHERS 207
11.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 207
11.5.1.1 NORTH AMERICA 207
11.5.1.2 EUROPE 207
11.5.1.3 ASIA-PACIFIC 208
11.5.1.4 SOUTH AMERICA 208
11.5.1.5 MIDDLE EAST & AFRICA 208
12 GLOBAL ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL 209
12.1 OVERVIEW 210
12.2 INDIRECT SALES 213
12.2.1 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE 213
12.2.1.1 OFFLINE 213
12.2.1.2 ONLINE 213
12.2.2 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 214
12.2.2.1 NORTH AMERICA 214
12.2.2.2 EUROPE 214
12.2.2.3 ASIA-PACIFIC 214
12.2.2.4 SOUTH AMERICA 214
12.2.2.5 MIDDLE EAST & AFRICA 214
12.3 DIRECT SALES 215
12.3.1 DIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 215
12.3.1.1 NORTH AMERICA 215
12.3.1.2 EUROPE 215
12.3.1.3 ASIA-PACIFIC 215
12.3.1.4 SOUTH AMERICA 215
12.3.1.5 MIDDLE EAST & AFRICA 216
?
13 GLOBAL ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 217
13.1 OVERVIEW 218
13.2 NORTH AMERICA 221
13.2.1 U.S. 231
13.2.2 CANADA 241
13.2.3 MEXICO 251
13.3 EUROPE 261
13.3.1 GERMANY 272
13.3.2 U.K. 282
13.3.3 FRANCE 292
13.3.4 ITALY 302
13.3.5 SPAIN 312
13.3.6 NETHERLANDS 322
13.3.7 BELGIUM 332
13.3.8 SWITZERLAND 342
13.3.9 SWEDEN 352
13.3.10 DENMARK 362
13.3.11 NORWAY 372
13.3.12 FINLAND 381
13.3.13 RUSSIA 391
13.3.14 TURKEY 400
13.3.15 REST OF EUROPE 410
13.4 ASIA PACIFIC 420
13.4.1 CHINA 431
13.4.2 JAPAN 441
13.4.3 INDIA 451
13.4.4 SOUTH KOREA 461
13.4.5 AUSTRALIA 471
13.4.6 INDONESIA 481
13.4.7 THAILAND 491
13.4.8 MALAYSIA 501
13.4.9 SINGAPORE 511
13.4.10 PHILIPPINES 520
13.4.11 NEW ZEALAND 529
13.4.12 HONG KONG 538
13.4.13 TAIWAN 547
13.4.14 REST OF ASIA-PACIFIC 555
?
13.5 MIDDLE EAST AND AFRICA 564
13.5.1 SAUDI ARABIA 575
13.5.2 UNITED ARAB EMIRATES 594
13.5.3 EGYPT 604
13.5.4 ISRAEL 613
13.5.5 QATAR 623
13.5.6 KUWAIT 632
13.5.7 OMAN 641
13.5.8 BAHRAIN 650
13.5.9 REST OF MIDDLE EAST AND AFRICA 659
13.6 SOUTH AMERICA 668
13.6.1 BRAZIL 679
13.6.2 ARGENTINA 689
13.6.3 COLOMBIA 699
13.6.4 CHILE 709
13.6.5 PERU 719
13.6.6 ECUADOR 728
13.6.7 VENEZUELA 737
13.6.8 URUGUAY 746
13.6.9 PARAGUAY 755
13.6.10 BOLIVIA 764
13.6.11 REST OF SOUTH AMERICA 773
14 GLOBAL ENDOSCOPIC HEMOSTASIS MARKET: COMPANY LANDSCAPE 783
14.1 COMPANY SHARE ANALYSIS: GLOBAL 783
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 784
14.3 COMPANY SHARE ANALYSIS: EUROPE 785
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 786
15 SWOT ANALYSIS 787
16 COMPANY PROFILES MANUFACTURERS 788
16.1 OLYMPUS CORPORATION 788
16.1.1 COMPANY SNAPSHOT 788
16.1.2 REVENUE ANALYSIS 788
16.1.3 COMPANY SHARE ANALYSIS 789
16.1.4 PRODUCT PORTFOLIO 789
16.1.5 RECENT DEVELOPMENT 790
?
16.2 BOSTON SCIENTIFIC CORPORATION 791
16.2.1 COMPANY SNAPSHOT 791
16.2.2 REVENUE ANALYSIS 791
16.2.3 COMPANY SHARE ANALYSIS 792
16.2.4 PRODUCT PORTFOLIO 792
16.2.5 RECENT DEVELOPMENT 793
16.3 CONMED CORPORATION 794
16.3.1 COMPANY SNAPSHOT 794
16.3.2 REVENUE ANALYSIS 794
16.3.3 COMPANY SHARE ANALYSIS 795
16.3.4 PRODUCT PORTFOLIO 795
16.3.5 RECENT DEVELOPMENT 796
16.4 MEDTRONIC 797
16.4.1 COMPANY SNAPSHOT 797
16.4.2 REVENUE ANALYSIS 797
16.4.3 COMPANY SHARE ANALYSIS 798
16.4.4 PRODUCT PORTFOLIO 798
16.4.5 RECENT DEVELOPMENT 799
16.5 COOK 800
16.5.1 COMPANY SNAPSHOT 800
16.5.2 COMPANY SHARE ANALYSIS 800
16.5.3 PRODUCT PORTFOLIO 801
16.5.4 RECENT DEVELOPMENT 802
16.6 ANKAFERD 803
16.6.1 COMPANY SNAPSHOT 803
16.6.2 PRODUCT PORTFOLIO 803
16.6.3 RECENT DEVEOPMENT 804
16.7 B. BRAUN SE 805
16.7.1 COMPANY SNAPSHOT 805
16.7.2 PRODUCT PORTFOLIO 805
16.7.3 RECENT DEVEOPMENT 805
16.8 CREO MEDICAL GMBH 806
16.8.1 COMPANY SNAPSHOT 806
16.8.2 PRODUCT PORTFOLIO 806
16.8.3 RECENT DEVELOPMENT 806
16.9 DIVERSATEK, INC. 807
16.9.1 COMPANY SNAPSHOT 807
16.9.2 PRODUCT PORTFOLIO 807
16.9.3 RECENT DEVEOPMENT 807
?
16.10 DUOMED GROUP 808
16.10.1 COMPANY SNAPSHOT 808
16.10.2 PRODUCT PORTFOLIO 808
16.10.3 RECENT DEVEOPMENT 809
16.11 ENDOCLOT PLUS, INC. 810
16.11.1 COMPANY SNAPSHOT 810
16.11.2 PRODUCT PORTFOLIO 810
16.11.3 RECENT DEVEOPMENT 811
16.12 ERBE ELEKTROMEDIZIN GMBH 812
16.12.1 COMPANY SNAPSHOT 812
16.12.2 PRODUCT PORTFOLIO 812
16.12.3 RECENT DEVELOPMENT 813
16.13 FUJIFILM HOLDINGS CORPORATION 814
16.13.1 COMPANY SNAPSHOT 814
16.13.2 REVENUE ANALYSIS 814
16.13.3 PRODUCT PORTFOLIO 815
16.13.4 RECENT DEVELOPMENT 819
16.14 JOHNSON & JOHNSON (ETHICON) 820
16.14.1 COMPANY SNAPSHOT 820
16.14.2 REVENUE ANALYSIS 820
16.14.3 PRODUCT PORTFOLIO 821
16.14.4 RECENT DEVEOPMENT 822
16.15 KARL STORZ SE & CO. KG, TUTTLINGEN 823
16.15.1 COMPANY SNAPSHOT 823
16.15.2 PRODUCT PORTFOLIO 823
16.15.3 RECENT DEVEOPMENT 823
16.16 MEDITALIA S.R.L. 824
16.16.1 COMPANY SNAPSHOT 824
16.16.2 PRODUCT PORTFOLIO 824
16.16.3 RECENT DEVELOPMENT 825
16.17 MICRO-TECH ENDOSCOPY 826
16.17.1 COMPANY SNAPSHOT 826
16.17.2 PRODUCT PORTFOLIO 826
16.17.3 RECENT DEVELOPMENT 827
16.18 MTW ENDOSKOPIE MANUFAKTU 828
16.18.1 COMPANY SNAPSHOT 828
16.18.2 PRODUCT PORTFOLIO 828
16.18.3 RECENT DEVEOPMENT 828
?
16.19 OVESCO ENDOSCOPY AG 829
16.19.1 COMPANY SNAPSHOT 829
16.19.2 PRODUCT PORTFOLIO 829
16.19.3 RECENT DEVEOPMENT 830
16.20 PENTAX MEDICAL 831
16.20.1 COMPANY SNAPSHOT 831
16.20.2 SOLUTION PORTFOLIO 831
16.20.3 RECENT DEVELOPMENT 831
16.21 STERIS 832
16.21.1 COMPANY SNAPSHOT 832
16.21.2 REVENUE ANALYSIS 832
16.21.3 PRODUCT PORTFOLIO 833
16.21.4 RECENT DEVELOPMENT 836
17 COMPANY PROFILES DISTRIBUTOR 837
17.1 BOSTON IVY HEALTHCARE SOLUTIONS PRIVATE LIMITED 837
17.1.1 COMPANY SNAPSHOT 837
17.1.2 PRODUCT PORTFOLIO 837
17.1.3 RECENT DEVELOPMENT 837
17.2 CARDINAL HEALTH 838
17.2.1 COMPANY SNAPSHOT 838
17.2.2 REVENUE ANALYSIS 838
17.2.3 PRODUCT PORTFOLIO 839
17.2.4 RECENT DEVEOPMENT 839
17.3 HENRY SCHEIN, INC. 840
17.3.1 COMPANY SNAPSHOT 840
17.3.2 REVENUE ANALYSIS 840
17.3.3 PRODUCT PORTFOLIO 841
17.3.4 RECENT DEVEOPMENT 841
17.4 MCKESSON MEDICAL-SURGICAL INC. 842
17.4.1 COMPANY SNAPSHOT 842
17.4.2 PRODUCT PORTFOLIO 842
17.4.3 RECENT DEVEOPMENT 843
17.5 MFI MEDICAL 844
17.5.1 COMPANY SNAPSHOT 844
17.5.2 PRODUCT PORTFOLIO 844
17.5.3 RECENT DEVEOPMENT 844
?
18 QUESTIONNAIRE 845
19 RELATED REPORTS 848
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security